Media Contact: Karen Beran PRESS RELEASE
Point of Care Decision Support, LLC For Immediate Release
email@example.com April 27, 2017
Point of Care Decision Support Names Jay Syverson President
Tim Michalski remains as CEO while Syverson is responsible for the strategy and execution of vision, growth and customer engagement
St. Paul, MN. (April 27, 2017) Point of Care Decision Support (PCDS), announced that Jay Syverson has been named President of the company. Syverson comes to his role with 35+ years of experience with multiple healthcare solutions companies, cross-industry consulting firms, as well as business intelligence and customer relationship management software & services companies. In his role as President, Jay is responsible for the strategy and execution of PCDS growth, customer engagement, as well as overall product vision for the healthcare marketplace guiding key clinical decisions and transitions of treatment at the point of care.
Prior to joining PCDS, Jay held many senior-level positions including President of Achieve Healthcare, Senior Vice President for Optum Data Management, Senior Vice President at Interelate, Vice President of Healthcare Practices for Coherent, CIO and Vice President of Technology for Boundary Medical, and Vice President of professional services at CWC-Firepond.
Although these roles were extremely diverse, the opportunities had several points of continuity including high growth and business transformation. In these roles, Syverson has executed consolidation and simplification initiatives driving over $100,000,000 in annual labor and environment consolidation savings over a three year period. At another organization, he also increased revenue per employee by 15 to 20 percent yearly. He did this while diversifying from one primary revenue channel into three revenue channels in a two-year span. Additionally, Syverson has successfully integrated off-shore technology resources into business unit operations, which effectively reduced costs by 70 percent and expanded capacity.
“I am excited and honored to take on this role as President of Patient Care Technology Systems. I look forward to delivering on the PCDS vision of continued development of intuitive healthcare tools that measure and improve the quality of patient care,” said Syverson. “The healthcare marketplace continues to undergo dynamic and dramatic change. PCDS expects to be a major driver of change in the healthcare ecosystem personalizing the connection between patients and care providers and improving the connection between providers of care and care provider networks.”
Tim Michalski, CEO, added, “Jay is an experienced executive leader with a number of positions at major technology healthcare companies. He has played an instrumental role in delivering results and driving sustainable growth, and has an impressive track record of strategic and operational accomplishments. He also brings to this position a strong reputation for developing people and inspiring teams.”
Jay holds a master’s degree (MBA) in business administration and a bachelor’s degree (BS) in business administration from Minnesota State University, Mankato.
About Point of Care Decision Support
Point of Care Decision Support, LLC (PCDS) is a healthcare software company that transforms evidence-based guidelines into intelligent tools for the point of care. With its Dynamic Decision Support Platform as a core anchor, PCDS builds intuitive healthcare tools that measure and improve the quality of patient care, provide real-time data and analysis, and have a meaningful and measurable return on investment. This provides consistency across every application to help patients and their healthcare providers manage chronic disease conditions. Interoperable with all major EMR/EHR systems, the Dynamic Decision Support Platform easily integrates new technology with existing investments, reducing implementation and operating costs. PCDS customers can more easily innovate and evolve with the changing needs of the business at a lower cost. Visit www.ptofcare.com to learn more about their anticoagulation (AC), asthma and other chronic disease applications in their solutions portfolio.